There are 23 resources available
Immunotherapy for Advanced Gastroesophageal Adenocarcinoma
Presenter: E. Smyth, UK
Session: Session 4 – Advanced Disease
Resources:
Slides
Participants Clinical Case Discussion - Addition of Durvalumab to Perioperative and Maintenance Therapy in Localised Advanced Cancer: Report of a Case
Presenter: B. Iglesias Martínez, ES
Session: Session 5 – Case discussion based on ESMO Clinical Practice Guidelines I
Resources:
Slides
Participants Clinical Case Discussion - A Perioperative Dilemma
Presenter: H. Clements, UK
Session: Session 5 – Case discussion based on ESMO Clinical Practice Guidelines I
Resources:
Slides
Participants Clinical Case Discussion - dMMR Elderly Patient Treated with Nivolumab
Presenter: M. Kysela, CZ
Session: Session 5 – Case discussion based on ESMO Clinical Practice Guidelines I
Resources:
Slides
Participants Clinical Case Discussion - Multimodal Treatment of Locally Advanced GEJ Cancer
Presenter: N. Milosevic, RS
Session: Session 5 – Case discussion based on ESMO Clinical Practice Guidelines I
Resources:
Slides
Participants Clinical Case Discussion - Post-FLOT Progression in PDL1 Gastric Cancer
Presenter: T. Pina Cabral, PT
Session: Session 5 – Case discussion based on ESMO Clinical Practice Guidelines I
Resources:
Slides
Participants Clinical Case Discussion - Neoadjuvant Immunotherapy for MSI-H/dMMR Gastric Cancer
Presenter: P. Manca, IT
Session: Session 5 – Case discussion based on ESMO Clinical Practice Guidelines I
Resources:
Slides
Participants Clinical Case Discussion - From stage IV to CR: An HER2 fairytale
Presenter: V. Nasca, IT
Session: Session 6 – Case discussion based on ESMO Clinical Practice Guidelines II
Resources:
Slides
Participants Clinical Case Discussion - The Role of Cytoreductive Surgery and HIPEC in Gastric Cancer with MSI-H Phenotype
Presenter: P.R. Rodrigues, PT
Session: Session 6 – Case discussion based on ESMO Clinical Practice Guidelines II
Resources:
Slides
Participants Clinical Case Discussion - A Case of a Patient with Oesophago-gastric Junction (OGJ) Adenocarcinoma in Stage IV: A Therapeutic Continuum
Presenter: G. Ricco, IT
Session: Session 6 – Case discussion based on ESMO Clinical Practice Guidelines II
Resources:
Slides